Tirzepatide Research

Tirzepatide (research designation LY3298176) is a synthetic 39-amino-acid peptide that activates both the GIP and GLP-1 receptors. It is the most extensively documented dual incretin agonist in the current literature, which makes it the usual reference point when newer poly-agonists are characterised.

This hub organises the Biovanta Research library for tirzepatide: its receptor pharmacology, the structure of its published research record, its behaviour as laboratory material, and the comparisons that place it against single and triple receptor agonists.

Start here

Foundational resources on the molecule and its dual receptor profile.

• What is Tirzepatide? — Definition, peptide class and receptor targets of tirzepatide as a laboratory research compound.
• Mechanism of Action — How tirzepatide engages the GIP and GLP-1 receptors, and how signalling bias between them is characterised.

Tirzepatide research material · Certificates of analysis · All research hubs

Research use only. Everything on this page describes published laboratory and preclinical research into a compound supplied strictly for in-vitro research by qualified persons. It is not medical advice, it does not describe human or veterinary use, and no dosing guidance is given.